His scientific interests lie mostly in Randomized controlled trial, Physical therapy, Health care, Public health and Surgery. His research in Randomized controlled trial intersects with topics in Survival rate, Clinical trial, Cause of death and Anxiety. Alastair Gray has researched Physical therapy in several fields, including Transgender hormone therapy, MEDLINE, Knee replacement, Severity of illness and Low back pain.
The concepts of his Health care study are interwoven with issues in Random effects model, Actuarial science, Medical emergency and Economic evaluation. His Public health study integrates concerns from other disciplines, such as Obesity, Absenteeism and Environmental health. His biological study spans a wide range of topics, including Stroke and Myocardial infarction.
His primary areas of study are Randomized controlled trial, Physical therapy, Health care, Internal medicine and Surgery. His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Clinical trial, Confidence interval, Family medicine and Quality of life. His Physical therapy study frequently involves adjacent topics like Quality-adjusted life year.
Alastair Gray has included themes like Environmental health, Gerontology, Public health and Economic evaluation in his Health care study. His work carried out in the field of Internal medicine brings together such families of science as Diabetes mellitus, Type 2 diabetes, Oncology and Cardiology. His work on Stroke expands to the thematically related Surgery.
Alastair Gray spends much of his time researching Internal medicine, Randomized controlled trial, Physical therapy, Surgery and Health care. Alastair Gray combines subjects such as Oncology and Cardiology with his study of Internal medicine. Alastair Gray combines subjects such as Statistics, MEDLINE and Quality of life with his study of Randomized controlled trial.
His Physical therapy research is multidisciplinary, relying on both Intervention, Hip fracture and Cost-effectiveness analysis. His Surgery research integrates issues from Coronary artery disease and Quality-adjusted life year. His Health care study combines topics in areas such as Gerontology, Family medicine and Economic evaluation.
Alastair Gray mainly investigates Randomized controlled trial, Internal medicine, Surgery, Physical therapy and Health care. His research in Randomized controlled trial intersects with topics in Placebo, Missing data, MEDLINE and Quality of life. His Internal medicine research focuses on subjects like Oncology, which are linked to Cetuximab and Cisplatin.
The study incorporates disciplines such as Coronary artery disease and Quality-adjusted life year in addition to Surgery. The Physical therapy study combines topics in areas such as Health economics, Confidence interval, Arthroscopy, Primary outcome and Rotator cuff. His biological study spans a wide range of topics, including Cluster randomised controlled trial, Psychological intervention, Ethnic group and Economic evaluation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The economic burden of back pain in the UK
Nikolaos Maniadakis;Alastair Gray.
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials
B Mihaylova;J Emberson;L Blackwell.
The Lancet (2012)
Economic burden of cardiovascular diseases in the enlarged European Union.
José Leal;Ramón Luengo-Fernández;Alastair Gray;Sophie Petersen.
European Heart Journal (2006)
Economic burden of cancer across the European Union: a population-based cost analysis
Ramon Luengo-Fernandez;Jose Leal;Alastair Gray;Richard Sullivan.
Lancet Oncology (2013)
European cardiovascular disease statistics
Steven Allender;Peter Scarborough;Vito Peto;Mike Rayner.
European Cardiovascular Disease Statistics 2012
Melanie Nichols;Nick Townsend;Ramon Luengo-Fernandez;Jose Leal.
Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema
Alasdair Gray;Steve Goodacre;David E. Newby;Moyra Masson.
The New England Journal of Medicine (2008)
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
P M Clarke;A M Gray;A Briggs;A J Farmer.
Applied Methods of Cost-effectiveness Analysis in Healthcare
A M Gray;P M Clarke;J Wolstenholme;S Wordsworth.
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
H Mehanna;M Robinson;A Hartley;A Kong.
The Lancet (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: